This site is intended for U.S. healthcare professionals.
Menu
Close
Ig Companion is available to support patients and caregivers
0 SBIs occurred in any patient during the 52-week efficacy study period1
Interactive calculator to determine a patient's dose, number of sites, and approximate time to complete infusion
Hear from John, a patient with PI, about his path to SCIg therapy and how cutaquig helped him
To report an adverse event, please call 1-800-438-1985
Pfizer for Professionals 1-800-505-4426
This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.
© 2024 Pfizer Inc. All rights reserved.
CUTAQUIG (Immune Globulin Subcutaneous [Human] - hipp) is a 16.5% immune globulin solution for subcutaneous infusion (IGSC), indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults and pediatric patients 2 years of age and older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Please see Full Prescribing Information, including BOXED WARNING and Patient Information and Instructions for Use.